4-Amino-1-((2R,3S,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one, 95.0%, 250mg

Levamisole>98.0%(HPLC)(T)250mg

Acido toluene-4-solfonico monoidrato, minimo 98%, per sintesi, 500 g, confezione in plastica.

4-((14-Amino-3,6,9,12-tetraoxatetradecyl)amino)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride, 98%, 500mg

3-{[4-methyl-5-(3-pyridinyl)-4H-1,2,4-triazol-3-yl]thio}propanoic acid, 95.0%, 250mg

1-(4-Methylphenyl)pyrrole-2-carboxaldehyde, 97.0%, 5g

Triisopropoxysilane,95%, 25g

((3-chloro-4-fluorophenyl)sulfonyl)glycine, 95.0%, 500mg

N-(4-Methoxybenzyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 5g

1-[3-(3-methylphenyl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 1g

Methyl 2,4-dibromo-5-fluorobenzoate, 97%, 500mg

2,2,3-TRIMETHYL-2,3-DIHYDROBENZOFURAN-6-OL, 95.0%, 100mg

3'-carboethoxy-2-(3-pyrrolinomethyl) benzophenone, 97.0%, 1g